- Vancouver Tech Journal
- Posts
- Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process
Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process
The CEO of GenXys on how his startup — through science and software — will put an end to one-size-fits-all treatments and bring prescriptions into the future.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/3863f4f8-3437-48af-a2b4-df8c3859a35c/bd5bbea4-8f11-422b-a001-ed6552d01ba1_600x600.jpg?t=1690482660)
Premium Content
Become a paying subscriber of Vancouver Tech Journal to get access to this page and other subscriber-only content.
What you get when you upgrade:
Already a subscriber?Sign In.Upgrade to view premium content.- 🔑 Exclusive content: In-depth stories that you won't find anywhere else
- 🎟️ First access to events we put on
- 🔒 The Morning Report, an email digest of need-to-know stories and deals
- 🗓️ Discounted and invitation-only events